Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed on September 23, 2025, and announced on September 24, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity under the second tranche of a buyback programme announced on July 31, 2025.
| Metric | Value |
|---|---|
| Total Shares Purchased | 5,150,000 |
| Price Range (pence) | 329.80 - 333.30 |
| Volume Weighted Average Price (pence) | 331.67 (approx) |
| Post-Transaction Treasury Shares | 33,337,545 |
| Registered Share Capital | 8,952,353,648 shares |
| Voting Shares Outstanding | 8,919,016,103 |
Material Changes
The primary material change is the reduction of shares outstanding due to the purchase of 5,150,000 ordinary shares. These shares are intended to be held as treasury shares. The filing does not disclose changes in operating performance compared to prior periods.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the share buyback programme. The filing states that the announcement does not constitute an offer or solicitation of securities. No specific guidance, risks, or contingencies regarding future financial performance are detailed in this specific report.
Investor Verification Checklist
- Verify the total cost of the 5,150,000 shares purchased against the reported volume-weighted average price.
- Confirm the updated number of voting shares (8,919,016,103) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check subsequent filings for the remaining capacity under the share buyback programme announced in July 2025.